NGE Intellectual Property partners Mike Harlin, Emer Simic and Tom Campbell recently authored the article "Method-of-Treatment Patents: Increasing Value & Risk," published by Life Science Connect.  Mike, Emer and Tom discuss how pharmaceutical companies are asserting their method-of-treatment patents more broadly, and highlight two recent cases that illustrate the potential for greater liability based on inducing infringement of method-of-treatment patents, which makes such patents more valuable.

Click here to read the article.